NAMPT and cancer: Both circulating levels and tissue expression of Nampt/PBEF/visfatin have been demonstrated to be upregulated in cancer, in which Nampt/PBEF/visfatin is believed to contribute to the disease progression by inducing proliferation, survival, and angiogenesis [2].